1. Administration errors involving Menveo examined in the US

   Clinical study 05 March 2016 Pages: 1 - 1

2. Draft guidance on reports for marketed products in Canada

   News item 05 March 2016 Pages: 2 - 2

3. Hyperkalaemia with spironolactone + renin-angiotensin system drugs

   News item 05 March 2016 Pages: 3 - 3

4. Hypomagnesaemia associated with PPI + bumetanide

   News item 05 March 2016 Pages: 4 - 4

5. New communication aids on risks of in utero valproate exposure

   News item 05 March 2016 Pages: 5 - 5

6. Opioids, benzodiazepines: calls for box warnings due to fatal overdose

   News item 05 March 2016 Pages: 6 - 6

7. Recall of Pharmakon's morphine for IV injection: super-potent

   News item 05 March 2016 Pages: 7 - 7

8. In utero exposure to B2AR agonists: risk of autism

   Clinical study 05 March 2016 Pages: 8 - 8

9. Direct ADR reports to FDA better than reports from companies

   Clinical study 05 March 2016 Pages: 9 - 9

10. HLA-B*15:02 screening in epilepsy not cost effective

    Clinical study 05 March 2016 Pages: 10 - 10

11. Inappropriate antimicrobial prescribing in patients with AAL

    Clinical study 05 March 2016 Pages: 11 - 11

12. Increased benzodiazepine use and overdose mortality in US

    Clinical study 05 March 2016 Pages: 12 - 12

13. Macrolides not associated with ventricular arrhythmia in elderly

    Clinical study 05 March 2016 Pages: 13 - 13

14. Acamprosate

    Case report 05 March 2016 Pages: 14 - 14

15. Acebrophylline

    Case report 05 March 2016 Pages: 15 - 15

16. Acitretin/sirolimus interaction

    Case report 05 March 2016 Pages: 16 - 16

17. Adalimumab/etanercept/infliximab

    Case report 05 March 2016 Pages: 17 - 17

18. Adenosine

    Case report 05 March 2016 Pages: 18 - 18

19. Aflibercept

    Case report 05 March 2016 Pages: 19 - 19

20. Alendronic acid

    Case report 05 March 2016 Pages: 20 - 20

21. Alendronic acid

    Case report 05 March 2016 Pages: 21 - 21

22. Aminolevulinic acid

    Case report 05 March 2016 Pages: 22 - 22

23. Amiodarone/beta adrenergic receptor antagonists

    Case report 05 March 2016 Pages: 23 - 23

24. Amobarbital

    Case report 05 March 2016 Pages: 24 - 24

25. Amoxicillin/clavulanic acid

    Case report 05 March 2016 Pages: 25 - 25

26. Amoxicillin/clavulanic acid/azithromycin

    Case report 05 March 2016 Pages: 26 - 26

27. Amygdalin/bitter apricot kernel

    Case report 05 March 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 05 March 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 05 March 2016 Pages: 29 - 29

30. Antineoplastics/epirubicin

    Case report 05 March 2016 Pages: 30 - 30

31. Antineoplastics/folinic acid

    Case report 05 March 2016 Pages: 31 - 31

32. Aspirin

    Case report 05 March 2016 Pages: 32 - 32

33. Aspirin/enalapril

    Case report 05 March 2016 Pages: 33 - 33

34. Azathioprine

    Case report 05 March 2016 Pages: 34 - 34

35. Azathioprine

    Case report 05 March 2016 Pages: 35 - 35

36. Azathioprine

    Case report 05 March 2016 Pages: 36 - 36

37. Azathioprine/cyclophosphamide/prednisone

    Case report 05 March 2016 Pages: 37 - 37

38. Azithromycin

    Case report 05 March 2016 Pages: 38 - 38

39. Bevacizumab

    Case report 05 March 2016 Pages: 39 - 39

40. Bicalutamide

    Case report 05 March 2016 Pages: 40 - 40

41. Botulinum toxin-a

    Case report 05 March 2016 Pages: 41 - 41

42. Brentuximab vedotin

    Case report 05 March 2016 Pages: 42 - 42

43. Buprenorphine/naloxone

    Case report 05 March 2016 Pages: 43 - 43

44. Carbimazole

    Case report 05 March 2016 Pages: 44 - 44

45. Carum/levothyroxine-sodium

    Case report 05 March 2016 Pages: 45 - 45

46. Cediranib

    Case report 05 March 2016 Pages: 46 - 46

47. Ceftriaxone

    Case report 05 March 2016 Pages: 47 - 47

48. Chlorhexidine

    Case report 05 March 2016 Pages: 48 - 48

49. Chlorpromazine/quetiapine/risperidone

    Case report 05 March 2016 Pages: 49 - 49

50. Ciclosporin

    Case report 05 March 2016 Pages: 50 - 50